Literature DB >> 32747599

Paracellular Pathway-Mediated Mycoplasma hyopneumoniae Migration across Porcine Airway Epithelial Barrier under Air-Liquid Interface Conditions.

Haiyan Wang1, Zhenzhen Zhang1, Xing Xie1, Beibei Liu1, Yanna Wei1, Yuan Gan1, Ting Yuan1, Bo Ni1, Jia Wang1, Lei Zhang1, Qiyan Xiong1, Guoqing Shao1, Zhixin Feng2.   

Abstract

Mycoplasma hyopneumoniae is an important respiratory pathogen of pigs that causes persistent and secondary infections. However, the mechanisms by which this occurs are unclear. In this study, we established air-liquid interface culture systems for pig bronchial epithelial cells (ALI-PBECs) that were comparable to the conditions in the native bronchus in vivo We used this ALI-PBECs model to study the infection and migration characteristics of M. hyopneumoniae in vitro Based on the results, we confirmed that M. hyopneumoniae was able to adhere to ALI-PBECs and disrupt mucociliary function. Importantly, M. hyopneumoniae could migrate to the basolateral chamber through the paracellular route but not the transcellular pathway, and this was achieved by reversibly disrupting tight junctions (TJs) and increasing the permeability and damaging the integrity of the epithelial barrier. We examined the migration ability of M. hyopneumoniae using an ALI-PBECs model for the first time. The disruption of the epithelial barrier allowed M. hyopneumoniae to migrate to the basolateral chamber through the paracellular route, which may be related to immune evasion, extrapulmonary dissemination, and persistent infection of M. hyopneumoniae.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Mycoplasma hyopneumoniaezzm321990; air-liquid interface; barrier function; migration; pig bronchial epithelial cells

Mesh:

Year:  2020        PMID: 32747599      PMCID: PMC7504950          DOI: 10.1128/IAI.00470-20

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Validation of ATP luminometry for rapid and accurate titration of Mycoplasma hyopneumoniae in Friis medium and a comparison with the color changing units assay.

Authors:  D Calus; D Maes; K Vranckx; I Villareal; F Pasmans; F Haesebrouck
Journal:  J Microbiol Methods       Date:  2010-09-17       Impact factor: 2.363

2.  Persistence of Mycoplasma hyopneumoniae in experimentally infected pigs after marbofloxacin treatment and detection of mutations in the parC gene.

Authors:  J Le Carrou; M Laurentie; M Kobisch; A V Gautier-Bouchardon
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 3.  Update on Mycoplasma hyopneumoniae infections in pigs: Knowledge gaps for improved disease control.

Authors:  D Maes; M Sibila; P Kuhnert; J Segalés; F Haesebrouck; M Pieters
Journal:  Transbound Emerg Dis       Date:  2017-08-23       Impact factor: 5.005

4.  Muc5b is required for airway defence.

Authors:  Michelle G Roy; Alessandra Livraghi-Butrico; Ashley A Fletcher; Melissa M McElwee; Scott E Evans; Ryan M Boerner; Samantha N Alexander; Lindsey K Bellinghausen; Alfred S Song; Youlia M Petrova; Michael J Tuvim; Roberto Adachi; Irlanda Romo; Andrea S Bordt; M Gabriela Bowden; Joseph H Sisson; Prescott G Woodruff; David J Thornton; Karine Rousseau; Maria M De la Garza; Seyed J Moghaddam; Harry Karmouty-Quintana; Michael R Blackburn; Scott M Drouin; C William Davis; Kristy A Terrell; Barbara R Grubb; Wanda K O'Neal; Sonia C Flores; Adela Cota-Gomez; Catherine A Lozupone; Jody M Donnelly; Alan M Watson; Corinne E Hennessy; Rebecca C Keith; Ivana V Yang; Lea Barthel; Peter M Henson; William J Janssen; David A Schwartz; Richard C Boucher; Burton F Dickey; Christopher M Evans
Journal:  Nature       Date:  2013-12-08       Impact factor: 49.962

5.  Simultaneous porcine circovirus type 2 and Mycoplasma hyopneumoniae co-inoculation does not potentiate disease in conventional pigs.

Authors:  M Sibila; M Fort; M Nofrarías; A Pérez de Rozas; I Galindo-Cardiel; E Mateu; J Segalés
Journal:  J Comp Pathol       Date:  2012-04-21       Impact factor: 1.311

6.  Disruption of tight junctions during traversal of the respiratory epithelium by Burkholderia cenocepacia.

Authors:  Jason Y Kim; Umadevi S Sajjan; Graham P Krasan; John J LiPuma
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 7.  A guide to polarized airway epithelial models for studies of host-pathogen interactions.

Authors:  Shakir Hasan; Peter Sebo; Radim Osicka
Journal:  FEBS J       Date:  2018-07-02       Impact factor: 5.542

Review 8.  Epithelial barrier function and immunity in asthma.

Authors:  Donna E Davies
Journal:  Ann Am Thorac Soc       Date:  2014-12

9.  Efficient suilysin-mediated invasion and apoptosis in porcine respiratory epithelial cells after streptococcal infection under air-liquid interface conditions.

Authors:  Fandan Meng; Nai-Huei Wu; Maren Seitz; Georg Herrler; Peter Valentin-Weigand
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

Review 10.  Modes of Action for Mucosal Vaccine Adjuvants.

Authors:  Taiki Aoshi
Journal:  Viral Immunol       Date:  2017-04-24       Impact factor: 2.257

View more
  3 in total

1.  Chloride channel accessory 1 gene deficiency causes selective loss of mucus production in a new pig model.

Authors:  Shamus P Keeler; Jennifer Yantis; Benjamin J Gerovac; Samuel L Youkilis; Stephanie Podgorny; Dailing Mao; Yong Zhang; Kristin M Whitworth; Bethany Redel; Melissa S Samuel; Kevin D Wells; Randall S Prather; Michael J Holtzman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-04-19       Impact factor: 6.011

2.  Pathogenicity & virulence of Mycoplasma hyopneumoniae.

Authors:  Fernanda M A Leal Zimmer; Jéssica Andrade Paes; Arnaldo Zaha; Henrique Bunselmeyer Ferreira
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

3.  Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice.

Authors:  Tao Hua; Chen Chang; Xuehua Zhang; Yuqing Huang; Haiyan Wang; Daohua Zhang; Bo Tang
Journal:  Front Microbiol       Date:  2022-09-15       Impact factor: 6.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.